Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard B Kim

Showing results (51-60 of 226) with videos related to

Pageof 23
Sort By:
Clinical Pharmacology and Therapeutics|January 30, 2004
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceCatia Marzolini, Erik Paus, Thierry Buclin, et al.
The New England Journal of Medicine|May 3, 2014
Genotype-guided dosing of vitamin K antagonistsUte I Schwarz, Richard B Kim, Rommel G Tirona
The Canadian Journal of Cardiology|February 4, 2018
Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel SyndromeP Timothy Pollak, Gavin R Sun, Richard B Kim
Pharmacogenetics and Genomics|June 11, 2014
Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohortSteven E Gryn, Wendy A Teft, Richard B Kim
International Journal of Molecular Sciences|September 9, 2023
Genetic Variation in miR-27a Is Associated with Fluoropyrimidine-Associated Toxicity in Patients with Dihydropyrimidine Dehydrogenase Variants after Genotype-Guided Dose ReductionSamantha Medwid, Theodore J Wigle, Cameron Ross, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Near Miss or Standard of Care? <i>DPYD</i> Screening for Cancer Patients Receiving FluorouracilLauren E Winquist, Michael Sanatani, Richard B Kim, et al.
Scientific Reports|February 7, 2020
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's diseaseAze Wilson, Ahmed Almousa, Wendy A Teft, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2025
Potential clinical relevance of rare dihydropyrimidine dehydrogenase genetic variants identified using whole-exome NextGen sequencing in cancer patients with severe fluoropyrimidine toxicityElizabeth Cui, Samantha Medwid, Ute I Schwarz, et al.
British Journal of Clinical Pharmacology|November 8, 2024
SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin-induced rhabdomyolysis: A case reportSamantha Medwid, Rowan Deckert, Steven E Gryn, et al.
British Journal of Pharmacology|July 23, 2003
Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transportersCarmine M Pariante, Richard B Kim, Andrew Makoff, et al.
Pageof 23

Showing results (51-60 of 226) with videos related to

Sort By:
Pageof 23
Clinical Pharmacology and Therapeutics|January 30, 2004
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevanceCatia Marzolini, Erik Paus, Thierry Buclin, et al.
The New England Journal of Medicine|May 3, 2014
Genotype-guided dosing of vitamin K antagonistsUte I Schwarz, Richard B Kim, Rommel G Tirona
The Canadian Journal of Cardiology|February 4, 2018
Personalized Anticoagulation: Guided Apixaban Dose Adjustment to Compensate for Pharmacokinetic Abnormalities Related to Short-Bowel SyndromeP Timothy Pollak, Gavin R Sun, Richard B Kim
Pharmacogenetics and Genomics|June 11, 2014
Profound reduction in the tamoxifen active metabolite endoxifen in a patient on phenytoin for epilepsy compared with a CYP2D6 genotype matched cohortSteven E Gryn, Wendy A Teft, Richard B Kim
International Journal of Molecular Sciences|September 9, 2023
Genetic Variation in miR-27a Is Associated with Fluoropyrimidine-Associated Toxicity in Patients with Dihydropyrimidine Dehydrogenase Variants after Genotype-Guided Dose ReductionSamantha Medwid, Theodore J Wigle, Cameron Ross, et al.
Current Oncology (Toronto, Ont.)|March 11, 2021
Near Miss or Standard of Care? <i>DPYD</i> Screening for Cancer Patients Receiving FluorouracilLauren E Winquist, Michael Sanatani, Richard B Kim, et al.
Scientific Reports|February 7, 2020
Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn's diseaseAze Wilson, Ahmed Almousa, Wendy A Teft, et al.
Cancer Chemotherapy and Pharmacology|December 3, 2025
Potential clinical relevance of rare dihydropyrimidine dehydrogenase genetic variants identified using whole-exome NextGen sequencing in cancer patients with severe fluoropyrimidine toxicityElizabeth Cui, Samantha Medwid, Ute I Schwarz, et al.
British Journal of Clinical Pharmacology|November 8, 2024
SLCO1B1 variants in a patient of African ancestry presenting with rosuvastatin-induced rhabdomyolysis: A case reportSamantha Medwid, Rowan Deckert, Steven E Gryn, et al.
British Journal of Pharmacology|July 23, 2003
Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transportersCarmine M Pariante, Richard B Kim, Andrew Makoff, et al.
Pageof 23